Arvinas Inc (ARVN)
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
Neogen Launches Second Edition Environmental Monitoring Handbook to Elevate Food Safety Practices
Biomerica, Inc. - Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
CORE-VNS Study Further Validates Effectiveness ofLivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Hoth Therapeutics Notification (HOTH)
Summit Plc - Summit Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
CNS Pharmaceuticals - New Press Release